Target intelligence / Profile preview

HeLa cell mitotic machinery

Molecular classification
Protein complex, Cytoskeletal components, Enzymes, Motor proteins
01

Overview

The HeLa cell mitotic machinery refers to the complex network of proteins and structural components, such as microtubules, centrosomes, and kinetochores, that orchestrate cell division in the HeLa cervical cancer cell line (Masters, 2002, Nature Reviews Cancer). This machinery is responsible for the accurate segregation of chromosomes during mitosis, a process that is highly accelerated and often deregulated in cancer cells (McIntosh, 2016, Cold Spring Harbor Perspectives in Biology). Key molecular components include tubulins, motor proteins like kinesins, and regulatory kinases such as Aurora kinases and Polo-like kinases (PubMed, PMC4852144). Because HeLa cells are a model for immortalized cancer growth, their mitotic machinery is a primary focus for developing antineoplastic agents. Drugs like taxanes and vinca alkaloids target this machinery by disrupting microtubule dynamics, leading to mitotic arrest and subsequent programmed cell death (Weaver, 2014, Molecular Biology of the Cell). While effective against tumors, these interventions often cause systemic toxicity due to their impact on normal dividing cells (StatPearls, NBK536911).

Other names
Mitotic apparatusSpindle apparatusCell division machineryMitotic spindle
02

Mechanism of action

Disruption of microtubule polymerization or depolymerization dynamics, or inhibition of essential mitotic kinases (e.g., Aurora kinases, Polo-like kinases), to induce mitotic arrest and subsequent apoptosis (Weaver, 2014, Molecular Biology of the Cell).

03

Biological functions

Cell cycleMitosisCell proliferationChromosome segregation
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionPeripheral neuropathyGastrointestinal toxicityAlopeciaNon-specific toxicity to healthy proliferating tissues
06

Interacting drugs

Paclitaxel

6 more in the full profile.

07

Biomarkers

Ki-67Phospho-histone H3 (pH3)Cyclin B1Polo-like kinase 1 (PLK1) expression

Beyond the preview

Go deeper on HeLa cell mitotic machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeLa cell mitotic machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call